| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-14 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-10 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.33 | 3e-09 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.27 | 2e-08 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.27 | 6e-07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |